Assura (LON:AGR) Stock Price Crosses Above 200 Day Moving Average – What’s Next?

Assura Plc (LON:AGRGet Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 48.01 and traded as high as GBX 48.50. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Peel Hunt restated a “buy” rating and issued a GBX 60 price target on shares of Assura in a report on Tuesday, September 30th. Shore Capital reissued a “hold” rating on shares of Assura in a research report on Wednesday, October 1st. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, Assura currently has a consensus rating of “Moderate Buy” and an average price target of GBX 60.

Read Our Latest Research Report on AGR

Assura Stock Performance

The firm has a market cap of £1.54 billion, a price-to-earnings ratio of 895.85, a P/E/G ratio of 3.60 and a beta of 0.37. The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. The business has a 50-day moving average of GBX 47.48 and a 200-day moving average of GBX 47.97.

About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Further Reading

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.